En Chu Kong Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01188824
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

attending physician of department of Traditional Chinese medicine | En Chu Kong Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

cilostazol (pletal) (1 trial)

Drugs in Phase 2 Trials (1)

astragalus membranaceus (1 trial)

Drugs in Other Trials (2)

calcitriol (rocaltrol) (1 trial)

cinacalcet (sensipar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 4)

Ischemia (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4